The Ritedose Corporation

We're #hiring a new Sr. Manufacturing Operations Manager in Columbia, South Carolina. Apply today or share this post with your network.

At Ritedose, we love our community and are continually finding ways to support those around us because we know they are supportive of us! No one in this life is ever doing it all alone. On Wednesday, we were proud to support Harvest Hope Food Bank, South Carolina’s largest food bank. We encourage anyone looking to support an incredible organization to visit one of their locations and join us in making a difference! #CommunitySupport #GivingBack

We had a great time at our company Field Day together raising money for the American Heart Association last month to support initiatives such as Hands Only CPR training, improved healthcare quality in the Midlands, provision of blood pressure cuffs and refrigeration to organizations in need, and funding research and technology that will save countless lives: https://lnkd.in/gHmSj_8i

Did you know? Outsourced pharmaceutical manufacturing is about to become half of the total drug-making market this year. CDMOs, CROs and CMOs make up the bulk of this manufacturing market. Do you know the difference between them? CRO—contract research organizations provide early-stage research and development services, from pre-clinical basic science discoveries to clinical trials. Many of them focus on clinical trial research, regulatory affairs, planning, data management logics and biostatistics that are beyond the means of most academic laboratories and can partner with larger pharmaceutical firms. CMO—contract manufacturing organizations are focused on helping pharmaceutical and biotechnology companies manufacture new therapeutics and vaccines. This can involve commercial production, development, stability testing and optimizing, formulations, and manufacturing methods. CDMO—contract development and manufacturing organizations, like Ritedose, provide comprehensive, fully integrated research, development and manufacturing support. This includes regulatory expertise, clinical trials, formulation development, packaging, fill-and-finish, supply chain, quality control, and technology transfer. These three main organizations can work in synchrony, as well. CROS and work with CDMOs, for example, to maintain a seamless pathway between research and final manufacturing steps. CMOs can also help fill capacity needs for CDMOs. Find out more about the CDMO services Ritedose provides to its existing and  potential customers!

Happy 4th of July! We could do the routine post about celebrating this holiday and put out a generic post, but we figured we’d do something to highlight a famous American chemist born today! ER Squibb was born on July 4th, 1819. A pioneering pharmacist, he founded the pharmaceutical company E.R. Squibb & Sons in 1858. His innovations and ethical standards significantly impacted the pharmaceutical industry, emphasizing rigorous quality control and the importance of ethical practices in medicine.

ICYMI: Exciting Expansion at Ritedose! We’re thrilled to announce an expansion of our sterile BFS capabilities, adding a 180-million-unit dose capacity for ophthalmic and respiratory medications. Starting this August at our state-of-the-art Columbia, SC facility, this brings our total BFS capacity to over 2.6 billion units, making us the largest BFS manufacturer in the US. Learn more: bit.ly/3VQsa3M #PharmaIndustry #PharmaManufacturing #DrugDelivery #InvestmentInSC

Check out our own Jody Chastain at SCbio’s “Biscuits & Bio,” a networking event that promotes the life sciences industry in SC and works to inspire attendees in a way that’s unique to the Palmetto State! #BiscuitsAndBio #LifeSciences #HealthInnovation

We’re thrilled to announce that we are expanding our sterile BFS capabilities with the addition of another 180-million-unit dose capacity for ophthalmic and respiratory medications which is expected to begin production in August of this year. The new capacity will be integrated into our state-of-the-art manufacturing facility in Columbia, SC. With the new expansion, Ritedose’s total BFS capacity will exceed 2.6 billion units—solidifying us as the largest BFS manufacturer in the US. “This expansion marks a pivotal moment in our company’s history. We’re passionately dedicated to advancing the health and well-being of patients across the United States—it’s why we come to work every single day. We are perfectly positioned to support our partners and deliver quality medications, and both they and our patients count on us to be steps ahead in capacity, capabilities and without a doubt, quality. It’s our forward-looking strategy and commitment that has allowed us to maintain a 100% customer retention rate over the past 25 years.” – Jody Chastain, Ritedose CEO Learn more at: bit.ly/3VQsa3M #PharmaIndustry #PharmaManufacturing #DrugDelivery #InvestmentInSC

Today, Ritedose honors Juneteenth—a day to remember, reflect, and rejoice.

Today, we honor those who made the ultimate sacrifice in service to our country and preserving our freedoms.